Hims & Hers Health, Inc. (HIMS) is a publicly traded company in the Healthcare — Medical - Care Facilities industry listed on NYSE. This overview shows the latest price, key valuation ratios, profitability metrics and financial-health indicators used by fundamental investors.
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers.
Is Hims & Hers Health, Inc. stock overvalued or undervalued in 2026?
As of October 29, 2026, Hims & Hers Health, Inc. (HIMS) trades at $29.67 with no positive earnings over the last twelve months, according to Kaplio. No valuation verdict: it has no earnings to calculate a P/E from.
Kaplio overview: Hims & Hers Health, Inc.
Market cap $7B · 52 weeks $15 – $47 (38 % below the high) · P/E no earnings · 2027 expected P/E 99.5× · Dividend none · Next earnings November 9, 2026 · expected EPS $0.06 · Closing price, Oct 29 · accounts published Aug 10.
- Valuation: P/Sales 1.6× (no earnings).
- Business: ROIC −4 % (weak).
- Balance sheet: Net debt/EBITDA 5.0× (fragile).
- Earnings: 4 of 8 (uneven).
What would it be worth at its usual multiples?
No valuation verdict: it has no earnings to calculate a P/E from.
What matters in pharma: 1 of 5 pass
- R&D / Revenue 6.4 %, fails.
- FCF / Net Income 57.6 %, fails.
- ROIC −3.7 %, fails.
- Net debt / EBITDA 5.0×, fails.
- Gross margin 73.8 %, passes, near the threshold.
Against its peers (reference peers) — Hims & Hers Health, Inc.: P/E —; EV/EBITDA —; ROIC -3.7 %; $6.7B. e.l.f. Beauty, Inc. (P/E 113×; EV/EBITDA 32.7×; ROIC 6.1 %; $6.7B), Coty Inc. (P/E —; EV/EBITDA 75.7×; ROIC 3.6 %; $3.0B), Kenvue Inc. (P/E 22.5×; EV/EBITDA 14.1×; ROIC 10.1 %; $37.6B).
Profitability
| Return on Equity | -30.03% |
| Return on Invested Capital | -3.73% |
| Return on Assets | -3.91% |
| Gross Margin | 64.68% |
| Operating Margin | -3.59% |
| Net Margin | -5.51% |
Financial Health
| Debt / Equity | 4.77 |
| Current Ratio | 0.93 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 4.10 |
Price Performance
| 1 month | -1.58% |
| 3 months | +5.58% |
| Year-to-date | -9.70% |
| 1 year | -33.45% |
| 3 years | +390.30% |
| 5 years | +275.90% |
Related companies: KVUE · EL · ELF · COTY · PRGO
Explore sector: Healthcare · Medical - Care Facilities
More sections of HIMS: Financials · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks